Results 261 to 270 of about 66,826 (280)

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Lancet, The, 2013
Cem Gabay, Paul Emery, Rieke E Alten
exaly  

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

Lancet, The, 2014
Josef S Smolen, Paul Emery, Roy M Fleischmann   +2 more
exaly  

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial

Lancet, The, 2019
Kristian Reich, Melinda Gooderham, D Thaçi   +2 more
exaly  

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

Lancet, The, 2016
Quan Dong Nguyen, Pauline T Merrill, Andrew D Dick   +2 more
exaly  

Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis

New England Journal of Medicine, 2017
Athimalaipet V Ramanan, Andrew D Dick, Ashley P Jones   +2 more
exaly  

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

New England Journal of Medicine, 2016
Alexa B Kimball, Alice B Gottlieb, Ka Papp   +2 more
exaly  

Adalimumab

Reactions Weekly
  +4 more sources

Adalimumab

Reactions Weekly, 2016
  +4 more sources

Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis

New England Journal of Medicine, 2022
exaly  

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

New England Journal of Medicine, 2008
Daniel J Lovell, Nicolino Ruperto, Katerina Jarosova   +2 more
exaly